GUYER WILLIAM (Chief Development Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/4/2026ACC: 0001193125-26-092157
Officer· Chief Development Officer
Since Aug 2021
+996.00
Net shares
Net buyer
$17.9K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
996.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+498.00
Price / share
$35.97
Trade value
$17.91K
% of position
40.3%
3/2/2026
1.24K→1.73K
Common Stock
Direct
Shares
+498.00
Price / share
—
Trade value
—
% of position
28.7%
3/2/2026
1.73K→2.23K
Total
Net shares
+996.00
Net value
$17.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +498.00 | $35.97 | $17.91K | 40.3% | 1.24K | 1.73K |
| Common Stock Direct | 3/2/2026 | A · Award | +498.00 | — | — | 28.7% | 1.73K | 2.23K |
| Total | +996.00 | $17.91K | ||||||
Derivative Transactions0
No derivative transactions reported